IE45534L - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
IE45534L
IE45534L IE771541A IE154177A IE45534L IE 45534 L IE45534 L IE 45534L IE 771541 A IE771541 A IE 771541A IE 154177 A IE154177 A IE 154177A IE 45534 L IE45534 L IE 45534L
Authority
IE
Ireland
Prior art keywords
group
active agent
pharmaceutical compositions
ca1095833a
aryloxyalkanolamines
Prior art date
Application number
IE771541A
Other versions
IE45534B1 (en
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of IE45534L publication Critical patent/IE45534L/en
Publication of IE45534B1 publication Critical patent/IE45534B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides a pharmaceutical composition for controlled release of an active agent in the intestinal tract comprisingi) a pharmacologically active agent selected from the group of arylalkanolamines and aryloxyalkanolamines, and ii) a physiologically tolerable anionic surfactant selected from the group of mono-sulphuric acid esters of higher fatty alcohols. [CA1095833A]
IE1541/77A 1976-07-27 1977-07-25 Improvements in or relating to organic compounds IE45534B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH958876 1976-07-27

Publications (2)

Publication Number Publication Date
IE45534L true IE45534L (en) 1978-01-27
IE45534B1 IE45534B1 (en) 1982-09-22

Family

ID=4353539

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1541/77A IE45534B1 (en) 1976-07-27 1977-07-25 Improvements in or relating to organic compounds

Country Status (27)

Country Link
JP (1) JPS5315411A (en)
AR (1) AR216479A1 (en)
AT (1) AT369987B (en)
AU (1) AU515738B2 (en)
BE (1) BE857122A (en)
CA (1) CA1095833A (en)
CY (1) CY1261A (en)
DE (1) DE2732335C2 (en)
DK (1) DK325677A (en)
ES (1) ES461020A1 (en)
FI (1) FI772217A7 (en)
FR (1) FR2359607A1 (en)
GB (1) GB1589982A (en)
GR (1) GR65014B (en)
HK (1) HK81884A (en)
HU (1) HU178340B (en)
IE (1) IE45534B1 (en)
IL (1) IL52587A (en)
KE (1) KE3441A (en)
MY (1) MY8400057A (en)
NL (1) NL176227C (en)
NO (1) NO149874C (en)
NZ (1) NZ184722A (en)
PT (1) PT66850B (en)
SE (1) SE437469B (en)
SG (1) SG53884G (en)
ZA (1) ZA774536B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH649216A5 (en) * 1979-08-16 1985-05-15 Sandoz Ag METHOD FOR APPLYING AN ACID-RESISTANT FILM TO A MEDICINAL CORE AND SOLID UNIT DOSAGE FORM WITH ACID-ACID RESISTANT FILM.
FR2471186A1 (en) * 1979-12-10 1981-06-19 Roussel Uclaf NEW COLIC DELITESCENCE TABLETS AND THEIR PREPARATION PROCESS
JPS6056122B2 (en) * 1980-05-21 1985-12-09 塩野義製薬株式会社 sustained release formulation
JPS5748908A (en) * 1980-09-08 1982-03-20 Kyorin Pharmaceut Co Ltd Prolonged release type nicomol pharmaceutical
US4795327A (en) * 1984-03-26 1989-01-03 Forest Laboratories, Inc. Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
US4540566A (en) * 1984-04-02 1985-09-10 Forest Laboratories, Inc. Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose
JPS61254522A (en) * 1985-05-02 1986-11-12 Takada Seiyaku Kk Tablet composition
JPS62246512A (en) * 1986-04-18 1987-10-27 Fujisawa Pharmaceut Co Ltd Drug preparation having repeating action
GB9714675D0 (en) * 1997-07-11 1997-09-17 Smithkline Beecham Plc Novel composition
DE19959419A1 (en) 1999-12-09 2001-06-21 Ratiopharm Gmbh Stable pharmaceutical preparations comprising a benzimidazole and process for their preparation
US20030113366A1 (en) * 2001-12-14 2003-06-19 Macgregor Alexander Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3148124A (en) * 1962-06-12 1964-09-08 William E Gaunt Method of preparing sustained release pharmaceutical tablets
CA927282A (en) * 1968-09-03 1973-05-29 S. Banker Gilbert Entrapment compositions and processes
GB1301849A (en) * 1969-12-15 1973-01-04
US3558768A (en) * 1969-12-19 1971-01-26 Sterling Drug Inc Sustained release pharmaceutical compositions

Also Published As

Publication number Publication date
AU515738B2 (en) 1981-04-30
ZA774536B (en) 1979-02-28
FR2359607B1 (en) 1980-02-22
ES461020A1 (en) 1979-05-01
NO149874B (en) 1984-04-02
MY8400057A (en) 1984-12-31
JPS5726650B2 (en) 1982-06-05
IL52587A0 (en) 1977-10-31
ATA541377A (en) 1982-07-15
IL52587A (en) 1980-09-16
SG53884G (en) 1985-03-08
SE7708265L (en) 1978-01-28
AR216479A1 (en) 1979-12-28
PT66850B (en) 1979-03-13
NZ184722A (en) 1980-10-24
FI772217A7 (en) 1978-01-28
AT369987B (en) 1983-02-25
NL176227B (en) 1984-10-16
KE3441A (en) 1984-09-14
NL7708162A (en) 1978-01-31
SE437469B (en) 1985-03-04
DK325677A (en) 1978-01-28
NL176227C (en) 1985-03-18
HK81884A (en) 1984-11-25
DE2732335C2 (en) 1983-01-20
DE2732335A1 (en) 1978-02-02
GR65014B (en) 1980-06-13
DK325877A (en) 1978-01-20
FR2359607A1 (en) 1978-02-24
GB1589982A (en) 1981-05-20
AU2730177A (en) 1979-02-01
CA1095833A (en) 1981-02-17
IE45534B1 (en) 1982-09-22
NO149874C (en) 1984-07-11
PT66850A (en) 1977-08-01
JPS5315411A (en) 1978-02-13
BE857122A (en) 1978-01-25
HU178340B (en) 1982-04-28
NO772575L (en) 1978-01-30
CY1261A (en) 1984-11-23

Similar Documents

Publication Publication Date Title
HK40583A (en) Nifedipine-containing solid preparation composition
IE790704L (en) Cyclosporin composition
GB1446626A (en) Composition for sustained release of a medicament and method of using same
IE940583L (en) Topical antimicrobial pharmaceutical compositions
IE42692L (en) Oestrogenic compositions
ES8200557A1 (en) Sustained release pharmaceutical composition of solid medical material
CA2104461A1 (en) Therapeutic compositions to protect and resuscitate mammalian cells and methods for preparing and using same
GR3017411T3 (en) Production process of microspheres.
JO2300B1 (en) Solid lipid formulations
JPS5294433A (en) Perfume blender
IE831226L (en) Method for preparing 26,26,26,27,27,27-hexafluoro-1ó,25-¹dihydrocholestrol
TWI255720B (en) Novel preparation and administration form comprising an acid-labile active compound and process for production thereof
EP0097374A3 (en) Corticosteroid topical preparation
NZ184722A (en) Pharmaceutical compositions with controlled release of active agent in the intestinal tract
CA2397942A1 (en) Controlled release pharmaceutical composition containing tramadol hydrochloride and method for its preparation
DE2860724D1 (en) Pseudomonic acid c, pharmaceutically acceptable salts or esters thereof, processes for their preparation and pharmaceutical or veterinary compositions containing them
JPS5350316A (en) Drug composition for oral administration
GB1381426A (en) Method of treating mammals and composition comprising oligosaccha ride sulphuric acid esters and nonionic surface active agents
JPS5236654A (en) Process for preparation of steroid derivatives
IE43994L (en) Diphenylmethanes.
JPS53127432A (en) Novel physiologically active substance, anthglutin, and its preparation
JPS5422344A (en) Cycloprophanecarboxylic acid esters, insecticides containing the same as active agent, and their preparation
AU1092095A (en) Intra-uterine ring for the release of an active agent, such as a hormone, and an introducer
JPS5251362A (en) Preparation of optically active pyrrolidine derivatives
NZ226696A (en) Tablet composition comprising a phthalazine acetic acid derivative as the active ingredient present in from 83-88 wt%

Legal Events

Date Code Title Description
MM4A Patent lapsed